Ivermectin has been medically prescribed to humans with severe parasitic infection for around 30 years. Ivermectin won the Nobel Prize for medications in 2015 and is on the World Health Organization's list of essential medicines. Stromectol is a modern, safe drug based on Ivermectin, with minimal side effects, low toxicity and excellent treatment results. Ivermectin has an established safety profile for human use (Gonzalez Canga et al., 2008; Jans et al., 2019; Buonfrate et al., 2019), and is FDA-approved for a number of parasitic infections (Gonzalez Canga et al., 2008; Buonfrate et al., 2019). Importantly, recent reviews and meta-analysis indicate that high dose ivermectin has comparable safety as the standard low-dose treatment, although there is not enough evidence to make conclusions about the safety profile in pregnancy (Navarro et al., 2020; Nicolas et al., 2020).
The controversy continues today over the use of Stromectol as a cure for Covid-19. Scientific research is not enough to officially approve Stromectol as the standard treatment for the virus, but numerous patient reviews and statistics indicate that Stromectol is indeed effective in the fight against coronavirus.